The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain. While symptoms can now be better managed with lifelong treatment, there is ...
Researchers at Johns Hopkins Medicine, in collaboration with researchers at the National Institutes of Health, report that two new studies in mice with a humanized immune system and human cell lines ...
The success of HIV entry inhibitors -- new drugs which prevent HIV entry into host cells -- are analyzed in a New Drug Class review in this week's edition of the Lancet. The study, by Dr Jose Este, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback